Compounds > atropine
Page last updated: 2024-09-05

atropine and netilmicin

atropine has been researched along with netilmicin in 7 studies

Compound Research Comparison

Studies
(atropine)		Trials
(atropine)		Recent Studies (post-2010)
(atropine)		Studies
(netilmicin)		Trials
(netilmicin)		Recent Studies (post-2010) (netilmicin)
26,7111,2591,6971,10819055

Protein Interaction Comparison

ProteinTaxonomyatropine (IC50)netilmicin (IC50)
30S ribosomal protein S6Escherichia coli K-120.02
30S ribosomal protein S7Escherichia coli K-120.02
50S ribosomal protein L15Escherichia coli K-120.02
50S ribosomal protein L10Escherichia coli K-120.02
50S ribosomal protein L11Escherichia coli K-120.02
50S ribosomal protein L7/L12Escherichia coli K-120.02
50S ribosomal protein L19Escherichia coli K-120.02
50S ribosomal protein L1Escherichia coli K-120.02
50S ribosomal protein L20Escherichia coli K-120.02
50S ribosomal protein L27Escherichia coli K-120.02
50S ribosomal protein L28Escherichia coli K-120.02
50S ribosomal protein L29Escherichia coli K-120.02
50S ribosomal protein L31Escherichia coli K-120.02
50S ribosomal protein L31 type BEscherichia coli K-120.02
50S ribosomal protein L32Escherichia coli K-120.02
50S ribosomal protein L33Escherichia coli K-120.02
50S ribosomal protein L34Escherichia coli K-120.02
50S ribosomal protein L35Escherichia coli K-120.02
50S ribosomal protein L36Escherichia coli K-120.02
30S ribosomal protein S10Escherichia coli K-120.02
30S ribosomal protein S11Escherichia coli K-120.02
30S ribosomal protein S12Escherichia coli K-120.02
30S ribosomal protein S13Escherichia coli K-120.02
30S ribosomal protein S16Escherichia coli K-120.02
30S ribosomal protein S18Escherichia coli K-120.02
30S ribosomal protein S19Escherichia coli K-120.02
30S ribosomal protein S20Escherichia coli K-120.02
30S ribosomal protein S2Escherichia coli K-120.02
30S ribosomal protein S3Escherichia coli K-120.02
30S ribosomal protein S4Escherichia coli K-120.02
30S ribosomal protein S5Escherichia coli K-120.02
30S ribosomal protein S8Escherichia coli K-120.02
30S ribosomal protein S9Escherichia coli K-120.02
50S ribosomal protein L13Escherichia coli K-120.02
50S ribosomal protein L14Escherichia coli K-120.02
50S ribosomal protein L16Escherichia coli K-120.02
50S ribosomal protein L23Escherichia coli K-120.02
30S ribosomal protein S15Escherichia coli K-120.02
50S ribosomal protein L17Escherichia coli K-120.02
50S ribosomal protein L21Escherichia coli K-120.02
50S ribosomal protein L30Escherichia coli K-120.02
50S ribosomal protein L6Escherichia coli K-120.02
30S ribosomal protein S14Escherichia coli K-120.02
30S ribosomal protein S17Escherichia coli K-120.02
30S ribosomal protein S1Escherichia coli K-120.02
50S ribosomal protein L18Escherichia coli K-120.02
50S ribosomal protein L2Escherichia coli K-120.02
50S ribosomal protein L3Escherichia coli K-120.02
50S ribosomal protein L24Escherichia coli K-120.02
50S ribosomal protein L4Escherichia coli K-120.02
50S ribosomal protein L22Escherichia coli K-120.02
50S ribosomal protein L5Escherichia coli K-120.02
30S ribosomal protein S21Escherichia coli K-120.02
50S ribosomal protein L25Escherichia coli K-120.02
50S ribosomal protein L36 2Escherichia coli K-120.02

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Glen, RC; Lowe, R; Mitchell, JB1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1

Other Studies

7 other study(ies) available for atropine and netilmicin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011